A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study
A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study
复制标题
一项针对转移性乳腺癌女性的高剂量化疗 (HDCT) 联合自体外周血干细胞支持 (asct) 与标准化疗 (ct) 进行比较的随机试验：加拿大国家癌症研究所 (NCIC) 临床试验组研究
DOI：
10.1016/s0959-8049(01)81543-4
复制
发表时间：
2001
影响因子：
8.4
通讯作者：
L. Shepherd
中科院分区：
文献类型：
--
作者：
S. Glück;M. Crump;D. Stewart;M. Levine;K. Pritchard;P. Kirkbride;J. Dancey;S. O'Reilly;T. Shore;S. Couban;C. Girouard;H. Abuzara;D. Tu;S. Marlin;L. Shepherd
